Who Owns Bio-Techne Stock?
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 98.97%
- Held by insiders
- 0.40%
- Institutional holders
- 795
- Institutions 99.0%
- Insiders 0.4%
- Public and other 0.6%
Who owns Bio-Techne stock?
Institutional investors own about 99.0% of Bio-Techne's shares, spread across 795 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.40% of TECH.
The largest institutional holders are Blackrock Inc. (9.07%), Vanguard Capital Management LLC (6.53%) and HBK Investments L P (4.92%). Together, the top 10 institutions control 43.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TECH positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TECH
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 14.25M | 9.07% | +1.6% |
| Vanguard Capital Management LLC | 10.25M | 6.53% | +0.3% |
| HBK Investments L P | 7.73M | 4.92% | +13.3% |
| Vanguard Portfolio Management LLC | 6.35M | 4.04% | -2.4% |
| FIL LTD | 6.27M | 3.99% | +158783.7% |
| State Street Corporation | 6.05M | 3.85% | +1.1% |
| Geode Capital Management, LLC | 5.43M | 3.46% | +1.5% |
| Goldman Sachs Group Inc | 4.14M | 2.64% | -43.6% |
| Invesco Ltd. | 3.78M | 2.40% | -24.3% |
| Balyasny Asset Management LP | 3.40M | 2.17% | +306.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TECH
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.97M | 3.16% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 4.06M | 2.58% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3.59M | 2.28% |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 2.71M | 1.72% |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 2.60M | 1.66% |
| iShares Trust-iShares Core S&P 500 ETF | 2.09M | 1.33% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 2.07M | 1.32% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 2.03M | 1.30% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.95M | 1.24% |
| MFS Series Trust IV-MFS Mid Cap Growth Fund | 1.81M | 1.16% |
Frequently asked questions
Who is the largest shareholder of Bio-Techne?
Blackrock Inc. is the largest institutional shareholder of TECH, owning 9.07% of shares outstanding (14.25M shares) as of its latest 13F filing.
What percentage of Bio-Techne is owned by institutions?
Institutions own about 99.0% of TECH shares and 99.4% of the public float.
How much of Bio-Techne do insiders own?
Insiders, such as officers and directors, own about 0.40% of TECH shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.